Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 230.65B, Merck(MRK) trades at $93.04. The stock has a price-to-earnings ratio of 12.29 and currently yields dividends of 3.5%.
As of 2025-11-15, Merck(MRK) stock has fluctuated between $91.15 and $95.08. The current price stands at $93.04, placing the stock +2.1% above today's low and -2.1% off the high.
The Merck(MRK)'s current trading volume is 19.63M, compared to an average daily volume of 12.87M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
MRK News
Close Key Takeaways Merck agreed to pay $9.2 billion to purchase Cidara Therapeutics, looking to cash in on the firm's experimental flu treatment. The $221.50...
(RTTNews) - Cidara Therapeutics, Inc. (CDTX) climbed 105.68% to $217.99, up $112.00, after it announced that Merck & Co. will acquire all outstanding shares for...
Cidara Therapeutics (CDTX) shares doubled, and then some, on Friday after Merck (MRK) agreed to buy the biotech company for $9.2 billion. The deal is "nothing...
Analyst ratings
57%
of 28 ratingsMore MRK News
Merck & Co. Inc. (NYSE:MRK) on Friday agreed to acquire Cidara Therapeutics, Inc. (NASDAQ:CDTX) for $221.50 per share in cash, for a total transaction value of...
Stock futures are trading lower this morning as investors wrestle with a growing sense that the Federal Reserve may not cut interest rates in December or at lea...
Merck & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the drugmaker’s respiratory portfolio and pi...
(RTTNews) - Merck (MRK) and Cidara Therapeutics, Inc. (CDTX) have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cida...
Merck (MRK) and Cidara Therapeutics (CDTX) announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will a...
06:50 EST Cidara Therapeutics (CDTX) jumps 104% to $216.26 after Merck (MRK) buyout offer Published first on TheFly – the ultimate source for real-time, market...
Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock. Merck (MRK +0.53%) has a...
